Download PDF
Hamostaseologie 1981; 01(01): 20-24
DOI: 10.1055/s-0038-1656585
Originalarbeiten
Schattauer GmbH

Fibrinolytische Behandlung bei akutem Herzinfarkt

B. Kirchhof
1   Medizinischen Klinik und Poliklinik – Abteilung A – der Westfälischen Wilhelms-Universität Münster
,
J. van de Loo
1   Medizinischen Klinik und Poliklinik – Abteilung A – der Westfälischen Wilhelms-Universität Münster
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • LITERATUR

  • 1 Benda L. Streptokinase und Blutviskosität beim akuten Herzinfarkt. In: Sailer S. (Hrsg.) Aktuelle Probleme der Fibrinoly-sebehandlung 1973. Hollinek; Wien: 27
    Google Scholar
  • 2 Bett J. H. N, Biggs J. C, Chesterman C. N. et al. Australian multicentre trial of streptokinase in acute myocardial infarction. Med. J. Aus 1977; 1: 553
    PubMedGoogle Scholar
  • 3 Chandler A. B, Chapman I, Erhardt L. R, Roberts W. C et al. Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Amer. J. Card 1974; 34: 823
    CrossrefPubMedGoogle Scholar
  • 4 Dewar H, Stephenson P, Horler A, Cassells-Smith A, Ellis P. Fibrinolytic therapy of coronary thrombosis. Brit. Med. J 1963; 1: 915
    CrossrefPubMedGoogle Scholar
  • 5 DeWood M. A, Spores J, Notske R. et al. Prevalance of the total coronary occlusion during the early hours of transmural myocardial infarction. New Engl. J. Med 1980; 303: 897
    CrossrefPubMedGoogle Scholar
  • 6 Duckert F, Burkart F, Hecker S, Bounameaux Y, Batschelet E. et al. Controlled trial of urokinase in myocardial infarction. Lancet 19752 624
    Google Scholar
  • 7 Ehrly A. M, Lange B. Reduction in blood viscosity and disaggregation of erythrocyte aggregate by streptokinase. In: Harter H. H, Copley L. A. (Hrsg.): Theoretical and clinical hemorrheology Springer, Heidelberg; New York: 1971: 366
    Google Scholar
  • 8 Erhardt L. R, Unge G, Boman G. Formation of coronary arterial thrombi in relation to onset of necrosis in acute myocardial infarction in man. Amer. Heart J 1976; 91: 592
    CrossrefPubMedGoogle Scholar
  • 9 European cooperative study group Streptokinase in acute myocardial infarction. New Engl. J. Med 1979; 301: 797
    CrossrefPubMedGoogle Scholar
  • 10 European cooperative study group Extended report of the European Cooperative Trial. In: (24).
    PubMedGoogle Scholar
  • 11 Fletcher A. P, Sherry S, Alkjaersig N, Smyrniotis F. E, Jick S. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thrombotic disorders. J. Clin. Invest 1959; 38: 1096
    CrossrefPubMedGoogle Scholar
  • 12 Gross R, Hartl W, Kloss G, Rahn B. Thrombolyse durch Infusionen hochgereinigter Streptokinase. Dtsch. Med. Wschr 1960; 85: 2129
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Hermens W. Th. Enzyme analysis in a multicenter trial on streptokinase treatment in acute myocardial infarction. In: (24)
    Google Scholar
  • 14 Lübcke P. Systemische Behandlung mit Streptokinase beim akuten Herzinfarkt. Med. Welt 1980; 31: 1056
    PubMedGoogle Scholar
  • 15 Mitchell J. R. A, Schwartz C. J. Arterial disease. Blackwell Scientific Publications; Oxford: 1965: 411
    Google Scholar
  • 16 Neuhof N, Hey D, Glaser E, Wolf H-G, Lasch H. Hemodynamic reactions induced by streptokinase therapy in patients with acute myocardial infarction. Europ. J. Int. Care Med 1975; 1: 27
    PubMedGoogle Scholar
  • 17 Praetorius F, Körtge P, Schneider B. et al. Kinetik der Serumenzyme bei Behandlung des Herzinfarktes mit Streptokinase. Klin. Wschr 1973; 51: 397
    CrossrefPubMedGoogle Scholar
  • 18 Rentrop P, Banke H, Karsch K. R, Kaiser H, Köstering H, Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation, in press
    Google Scholar
  • 19 Rentrop P, Blanke H, Karsch K. R, Köstering H, Oster H, Leitz H. Recanaliza-tion of an acutely occluded aortocoronary Bypass by intragraft fibrinolysis. Circulation 1980; 62: 1123
    CrossrefPubMedGoogle Scholar
  • 20 Ruegsegger P, Nydick I, Robert C, Hutter C. et al. Fibrinolytic (plasmin) therapy of experimental coronary thrombi with alteration of the evolution of myocardial infarction. Circulation 1959; 29: 7
    PubMedGoogle Scholar
  • 21 Schmid-Schönbein H, Rieger H, Hess H. Quantitative Erfassung der Effekte fibrino-lytischer Therapie auf das Fließverhalten des Blutes. Klin. Wschr 1977; 55: 111
    CrossrefPubMedGoogle Scholar
  • 22 Theiss W, Wirtzfeld A. Coagulation studies and rheological considerations in a subsample of patients of the European trial of streptokinase in acute myocardial infarction. In: (24).
    Google Scholar
  • 23 Verstraete M. Probleme und Unsicherheiten thrombolytischer Substanzen der zweiten Generation. In: Deutsch E, Lechner K. (Hrsg.): Fibrinolyse, Thrombose, Hämosta-se Schattauer, Stuttgart; New York: 1980
    Google Scholar
  • 24 Verstraete M, van de Loo J, Jesdinsky H. (Hrsg.) Streptokinase in acute myocardial infarction. Acta Med. Scand 1981. (im Druck)
    Google Scholar
  • 25 Wende W, Stühlen H. W, Bleifeld W, Holzhüter H, Wenzel E. Die Größe des akuten tierexperimentellen Herzinfarktes unter Streptokinase-induzierter Fibrinolyse. Klin. Wschr 1973; 53: 755
    PubMedGoogle Scholar
  • 26 Willems J. L, Theiss W, Lübcke P. Arrhythmias in patients with acute myocardial infarction treated with streptokinase. In: (24)
    Google Scholar